Re: WHY breast cancer treatment can never be "one size fits all"
Like the salad metaphor, Lani. This is interesting, but do you think extensive molecular and genetic testing on all tumors will ever become the norm due to the associated expense? Much of this lab work currently runs in the 3-5k price range and that is just for the standard ki67. It would be wonderful to have the knowledge, but just as with our propensity to mets to the CNS where routine MRI screening is suggested, the expense vs benefit becomes the prevailing limitation.
__________________
Smile On!
Laurel
Dx'd w/multifocal DCIS/IDS 3/08
7mm invasive component
Partial mast. 5/08
Stage 1b, ER 80%, PR 90%, HER-2 6.9 on FISH
0/5 nodes
4 AC, 4 TH finished 9/08
Herceptin every 3 weeks. Finished 7/09
Tamoxifen 10/08. Switched to Femara 8/09
Bilat SPM w/reconstruction 10/08
Clinical Trial w/Clondronate 12/08
Stopped Clondronate--too hard on my gizzard!
Switched back to Tamoxifen due to tendon pain from Femara
15 Years NED
I think I just might hang around awhile....
|